- Home
- ORIC vs LENZ Comparison
ORIC vs LENZ Comparison
Compare ORIC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- LENZ
- Stock Information
- Founded
- ORIC 2014
- LENZ 2019
- Country
- ORIC United States
- LENZ United States
- Employees
- ORIC N/A
- LENZ N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- ORIC Health Care
- LENZ Health Care
- Exchange
- ORIC Nasdaq
- LENZ Nasdaq
- Market Cap
- ORIC 1.1B
- LENZ 1.2B
- IPO Year
- ORIC 2020
- LENZ 2021
- Fundamental
- Price
- ORIC $14.19
- LENZ $46.21
- Analyst Decision
- ORIC Strong Buy
- LENZ Strong Buy
- Analyst Count
- ORIC 8
- LENZ 4
- Target Price
- ORIC $16.57
- LENZ $49.75
- AVG Volume (30 Days)
- ORIC 1.6M
- LENZ 546.3K
- Earning Date
- ORIC 11-11-2025
- LENZ 11-05-2025
- Dividend Yield
- ORIC N/A
- LENZ N/A
- EPS Growth
- ORIC N/A
- LENZ N/A
- EPS
- ORIC N/A
- LENZ N/A
- Revenue
- ORIC N/A
- LENZ $5,000,000.00
- Revenue This Year
- ORIC N/A
- LENZ N/A
- Revenue Next Year
- ORIC N/A
- LENZ $285.82
- P/E Ratio
- ORIC N/A
- LENZ N/A
- Revenue Growth
- ORIC N/A
- LENZ N/A
- 52 Week Low
- ORIC $3.90
- LENZ $16.54
- 52 Week High
- ORIC $14.93
- LENZ $50.40
- Technical
- Relative Strength Index (RSI)
- ORIC 71.68
- LENZ 58.66
- Support Level
- ORIC $13.85
- LENZ $45.20
- Resistance Level
- ORIC $14.93
- LENZ $49.25
- Average True Range (ATR)
- ORIC 0.81
- LENZ 2.38
- MACD
- ORIC 0.35
- LENZ 0.10
- Stochastic Oscillator
- ORIC 85.29
- LENZ 62.70
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.